Akknatek provides solutions for ophthalmology, with the aim of improving cataract surgery.
Akknatek's investors include European Innovation Council, Luminate.
Akknatek is headquartered in Kaiserslautern, Germany.
Akknatek provides solutions for ophthalmology, with the aim of improving cataract surgery.
Akknatek is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akknatek — Funding & Investors." VCBacked, December 19, 2022, https://www.vcbacked.co/company/akknatek. Accessed October 30, 2026.
VCBacked. (2022). Akknatek — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/akknatek
{{cite web |title=Akknatek — Funding & Investors |url=https://www.vcbacked.co/company/akknatek |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated